期刊文献+

上海地区妇女乳腺癌组织PIK3CA基因热点突变区域研究 被引量:4

Mutational hotspots of PIK3CA in breast cancer among Chinese women in shanghai
原文传递
导出
摘要 目的:探讨乳腺癌组织中磷脂酰肌醇-3-激酶催化亚单位α(PIK3CA)基因2个热点突变区域第9和第20外显子的突变,以及该突变与乳腺癌临床病理特征之间的关系。方法:45例乳腺癌标本提取DNA后,对第9及第20外显子进行PCR扩增,产物纯化后测序。另取10例乳腺良性肿瘤组织标本作为对照。结果:在45例乳腺癌组织标本中共发现14例(31%)PIK3CA基因突变,其中第9外显子8例(57%),第20外显子6例(43%)。在第9外显子突变中,1例为C1616G(P539R),1例为G1633A(E545K),6例为A1634C(E545A)。第20外显子的6例突变均为A3140G(H1047R)。10例良性肿瘤对照中均未发现突变。第9与第20外显子突变在浸润性导管癌和浸润性小叶癌中的分布差异无统计学意义,P>0.05。PIK3CA基因突变与患者年龄、肿瘤大小、淋巴结状态、ER/PR状态、HER-2表达和p53表达之间无明显相关性,P>0.05。结论:PIK3CA基因可能与乳腺癌的发生、发展及预后相关。但PIK3CA基因突变与乳腺癌临床病理特征之间无明显相关性。 OBJECTIVE:To investigate the two mutational hotspots in exon 9 and exon 20 of PIK3CA gene in breast cancer,and the association of the mutation with the pathological features of breast cancer. METHODS: PCR amplification of exons 9 and 20 was done after extracting DNA from 45 samples of breast cancer,followed by sequence after the product was purified. Another 10 samples of benign breast tumor were chosen as controls. RESULTS: 14(31%) missense mutations,8(57%) in exon 9,6(43%) in exon 20 were found. In eight cases of exon 9,1 was C1616G (P539R),1 was G1633A (E545K),and 6 were A1634C (E545A). All the 6 cases of mutations in exon 20 were A3140G (H1047R). No mutation was found in 10 cases of benign breast tumor. There was no significant difference in the distribution of mutation between invasive ductal carcinoma and invasive lobular carcinoma in both exon 9 and exon 20(P〉0.05). The mutation of PIK3CA gene had no significant correlation with the age,tumor size,lymph node status,ER/PR status,HER-2 expression,and p53 expression(P〉0.05). CONCLUSIONS: PIK3CA gene may be associated with the development and prognosis of breast cancer. However,there is no significant correlation between PIK3CA gene mutation and the pathological features of breast cancer.
出处 《中华肿瘤防治杂志》 CAS 2009年第18期1365-1367,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 上海市科学技术委员会资助项目(06DZ19505)
关键词 PIK3CA 基因 突变 乳腺肿瘤/流行病学 PIK3CA gene mutation breast neoplasms/epidemilogy
  • 相关文献

参考文献18

  • 1Volinia S, Hiles I,Ormondroyd E,et al. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene[J]. Genomics,1994,24(3) :472- 477.
  • 2Kang S, Bader A G, Vogt P K. Phosphatidylinositol 3-kinase mutations identified in hunman cancer are oncogenic[J]. Proc Natl Acad Sci U S A, 2005,102 (3) : 802-807.
  • 3Cantley L C. The phosphoinositide 3-kinase pathway[J]. Science,2002,296(5573) :1655-1657.
  • 4Ma Y Y,Wei S J,Lin Y C, et al. PIK3CA as a oncogene in cervical cancer[J]. Oncogene,2000,19(23) :2739-2744.
  • 5Woenckhaus J, Steger K,Werner E, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma [J]. J Pathol, 2002,198(3) :335- 342.
  • 6Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers[J]. Science,2004, 304(5670) :554.
  • 7Campbell I G,Russell S E,Choong D Y,et al. Mutation of the PIK3CA gene in ovarian and breast cancer[J]. Cancer Res, 2004,64(21) :7678-7681.
  • 8Li V S, Wong C W,Chan T L,et al. Mutations of PIK3CA in gastric adenocarcinoma[J]. BMC Cancer, 2005,5 : 29.
  • 9Lee J W,Soung Y H,Kim S Y,et al. PIK3CA gene is frequently mutated in breast and hepatocellular carcinomas[J]. Oncogene, 2005,24(8) :1477-1480.
  • 10Levine D A,Bogomolniy F,Yee C J, et al. Frequent mutation of the PIK3CA gene in Ovarian and breast cancers[J]. Clin Cancer Res,2005,11(8) :2875-2878.

同被引文献34

  • 1陈琳玲,张佳,彭翠英,廖端芳,李弘剑,高汉林,李凯.DNA聚合酶高保真机理的新发现及其在SNP分析中的应用[J].遗传,2005,27(2):279-283. 被引量:8
  • 2王红洁,蔡蓉,卢健.PIK3CA基因突变与癌症的关系[J].医学分子生物学杂志,2006,3(5):347-349. 被引量:2
  • 3陆兴热 高仕萍 刘孝文等.RNA干扰介导的PIK3CA基因沉默抑制Hep-2细胞增殖和侵袭力.中华检验医学杂志,2010,33(3):83-84.
  • 4Li V, Wong C, Chan T, et al. Mutations of PIK3CA in gastric adenocarcinoma[J]. BMC Cancer, 2005,5:29.
  • 5Troxell ML, Levine J, Beadling C, et al. High prevalence of PIK3CA /AKT pathway mutations in papillary neoplasms of the breast[J]. Mod Pathol, 2010, 23(1): 27-37.
  • 6Kostakis GC, Papadogeorgakis N, Koumaki V, et al. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 109(5): 53-58.
  • 7Hafner C, Landthaler M, Vogt T, et al. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations [J]. Exp Dermatol, 2010, 19(8): 222-227.
  • 8Saridaki Z, Tzardi M, Papadaki C, et al. Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥ 2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients[J]. PLoS One, 2011, 6(1): e15980.
  • 9Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers [J]. Science 2004, 304:554.
  • 10Thomas RK, Baker AC, DeBiasi RM, et al. High-throughput oncogene mutation profiling in human cancer [J]. Nat Genet, 2007, 39(3): 347-351.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部